TEM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tempus AI Inc (TEM) appears to be a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is currently undervalued, with hedge funds significantly increasing their positions, strong growth in financials, and positive analyst sentiment outweighing the negatives. While there are no immediate trading signals, the company's fundamentals and future growth potential in AI and genomics make it a compelling long-term investment.
The MACD is positive at 0.951, indicating bullish momentum. RSI is neutral at 45.589, and moving averages are converging, suggesting consolidation. The stock is trading above its pivot level of 50.951, with key resistance at 56.922 and support at 44.98. Overall, the technical indicators suggest a neutral to slightly bullish trend.
Hedge funds are aggressively buying, with an 884.13% increase in positions last quarter.
Analysts highlight Tempus AI's strong position in AI-driven diagnostics and genomics, with potential for growth in
Revenue grew by 82.98% YoY in Q4 2025, and gross margin improved to 64.73%.
Jefferies initiated an Underperform rating, citing concerns about the company's data business and lack of clear catalysts.
Insider trading activity is neutral, with no significant trends.
The stock has declined over 50% in the last six months, reflecting market skepticism.
In Q4 2025, Tempus AI reported revenue growth of 82.98% YoY to $367.2M. Net income improved significantly, up 316.21% YoY, though it remains negative at -$54.17M. EPS improved by 275% to -0.3, and gross margin increased to 64.73%. These figures indicate strong growth momentum despite ongoing losses.
Analysts are mixed but lean positive. TD Securities upgraded the stock to Buy with a $65 target, citing undervaluation and growth potential in AI and genomics. Guggenheim and Morgan Stanley maintain Buy and Overweight ratings, respectively, with adjusted price targets reflecting recent market conditions. Jefferies is cautious, initiating an Underperform rating with a $35 target due to concerns about the company's data business and lack of catalysts.
